Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Xylem €500 Million Senior Notes Offering
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Xylem Inc. of €500 million aggregate principal amount of its 2.250% notes due 2023. Xylem…
Pfizer Inc. $5 Billion Accelerated Share Repurchase
Davis Polk advised the counterparty in connection with an accelerated share repurchase transaction entered into between the counterparty and Pfizer Inc. (“Pfizer”), pursuant to which Pfizer…
IBM €2.25 Billion Notes Offering
Davis Polk advised the underwriters in connection with a public offering by International Business Machines Corporation of €1 billion principal amount of its 0.500% notes due 2021, €750…
Back to top